Galapagos licenses HUB Organoid Technology for use in cystic fibrosis and IBD research
15 July 2015 | By Victoria White
Galapagos has entered into a licensing agreement with the HUB foundation for use of Organoid Technology for preclinical research in cystic fibrosis and IBD...